Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07140770
Status
Recruiting
Apply to this trial

Conditions

  • Allogenic Hematopoietic Cell Transplant
  • Physical Activity
  • Sleep

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Fitbit — DEVICE
    You will wear the tracker on your wrist like a watch and it will continuously (non-stop) monitor your activity, sleep, and heart rate. Functional testing will be completed with a research team member and will consist of 2 tests: testing your grip strength by having you squeeze a measuring device 3 times with your dominant hand and measuring how many minutes it takes for you to walk 15 feet.
  • Questionnaire — OTHER
    Complete questionnaires at 3 timepoints, at the time of enrollment on the day of allogeneic hematopoietic cell transplantation, 8 days after allogeneic hematopoietic cell transplantation, and 7 days after hospital discharge.

Study Details

To understand the changes in health-related quality of life of patients and caregivers after allogeneic hematopoietic cell transplantation.

Key Dates

Start date
Sep 2, 2025
Status verified
Mar 2026
Primary completion
Apr 1, 2026
Completion
Apr 1, 2028

Study Design

Enrollment
66 participants (estimated)

Primary Outcome Measure

Quality of Life Questionnaire [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Eileen D Hacker, MD
[email protected]
713-563-4004
Eileen D Hacker, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
MD Anderson Cancer Center· Houston, TX

Related Studies